How Is Interstitial 1064 Nm Nd:yag Laser Vaporization Performed On Deep Fibrotic Keloids, And What Safety Precautions Prevent Thermal Necrosis? Discover The Technique And Safeguards

Interstitial 1064 nm Nd:YAG laser vaporization is performed by placing a bare optical fiber into the center of a dense keloid, delivering controlled deep laser energy while slowly withdrawing the fiber. For fibrotic keloids approximately 1 cm or larger, a 400 or 600 µm fiber is introduced through a puncture guide, with positioning aided by ultrasound or the pilot beam. Vaporization commonly uses 30–35 W, delivered continuously or in short 0.1–0.3 second chopped pulses, while continuous temperature surveillance and immediate cooling limit epidermal injury and deep thermal necrosis.

The essential safety principle is controlled energy movement combined with real-time skin-surface temperature monitoring. The objective is to reduce and remodel the internal scar without causing epidermal charring, infarction, ulceration, or sloughing.

How the Procedure Targets Deep Fibrotic Keloids

Selecting Appropriate Lesions

Interstitial treatment is intended for large, dense, fibrotic keloids, particularly lesions with a substantial deep component and a diameter of roughly 1 cm or greater. The technique places energy within the scar rather than relying solely on transcutaneous penetration.

This approach is generally more relevant to thick, resistant lesions than to small, thin, or primarily superficial scars. Patient selection, diagnosis, and parameter selection require an appropriately trained laser or scar specialist.

Introducing the Optical Fiber

A 400 µm or 600 µm bare optical fiber is inserted into the lesion through a puncture guide. The fiber is directed toward the keloid center, where the internal fibrotic tissue can be treated more directly.

Positioning may be assisted by ultrasound or by visualization of the pilot beam. Accurate placement matters because energy delivered too close to the epidermis increases the risk of surface injury, while energy concentrated in one deep location can create a focal zone of coagulation or necrosis.

Delivering and Distributing Energy

The reference protocol describes delivery at approximately 30–35 W, using either continuous-wave treatment or chopped pulses lasting 0.1–0.3 seconds. The operator slowly retracts the fiber during treatment so that the vaporization pathway is distributed through the scar.

The fiber should not remain stationary. Continuous, controlled movement and treatment across multiple internal paths reduce the likelihood of creating a single excessive thermal zone.

Repeating Treatment When Necessary

Treatment may be repeated at intervals of approximately 8–10 weeks, depending on the volume of residual keloid. This interval allows the treated tissue to cool, heal, and remodel before the next assessment.

Repeat treatment should be based on the remaining clinical volume and tissue response rather than on a fixed number of sessions.

Why 1064 nm Nd:YAG Energy Can Help

Deep Vascular and Fibrotic Effects

The 1064 nm wavelength penetrates deeply into the dermis and can affect the microvasculature supplying the keloid. Vascular injury and reduced microcirculation may decrease the biological signals that support continued collagen production.

Over time, reduced scar vascularity and altered collagen turnover can contribute to flattening, softening, and lightening of the lesion.

Effects on Scar Remodeling

The treatment is intended to reduce excessive collagen activity while allowing normal collagenolytic processes to continue. The broader biological response may include reduced expression of pro-inflammatory and profibrotic signals, including transforming growth factor-beta 1, together with increased matrix-remodeling activity.

These effects are progressive. Laser vaporization should therefore be understood as part of a staged scar-management strategy rather than an immediate removal technique.

Why Deep Delivery Is Useful

Deep fibrotic keloids can contain collagen bundles and vessels that are difficult to reach adequately with superficial treatment. Interstitial delivery places the fiber within the lesion, allowing energy to act closer to the deep scar base.

The same penetration that provides this advantage also creates the principal hazard: thermal energy can spread beyond the intended target into normal dermis, epidermis, nerves, or adjacent structures.

Preventing Thermal Necrosis

Monitor the Skin Surface Continuously

Strict skin-surface temperature monitoring is the central precaution. Digital temperature feedback is preferred where available; manual assessment can supplement it but should not replace objective monitoring when the system supports feedback.

Monitoring must continue during energy delivery because internal heating can evolve rapidly, particularly when the fiber is moving through dense tissue or when treatment paths overlap.

Keep the Fiber Moving

The operator should slowly retract the fiber during delivery and avoid prolonged stationary activation. Multiple controlled passes or paths distribute energy more evenly and reduce the risk of unpredictable hot spots.

Pulse chopping can also help limit heat accumulation, but it does not eliminate the need for temperature monitoring, movement, and appropriate power selection.

Prevent Surface Injury

The desired endpoint is internal scar treatment without epidermal damage. Blanching, epidermal charring, frank coagulation, or visible tissue injury indicates excessive or poorly distributed thermal exposure and should prompt immediate reassessment of the treatment parameters.

Surface defects are clinically important because they can lead to delayed healing and increase the likelihood of recurrent, more aggressive scar formation.

Apply Immediate Cooling

Immediate post-laser cooling should be applied to the treated area. Cooling limits residual heat diffusion and helps protect the epidermis and surrounding dermis after energy delivery has stopped.

Cooling should be integrated into the procedure rather than postponed until discomfort or visible injury develops.

Avoid Treatment to Infarction

Over-treatment can cause tissue infarction, sloughing, ulceration, and healing by secondary intention. These complications substantially increase the risk of problematic wound healing and keloid recurrence.

The goal is controlled reduction and remodeling of the lesion, not destruction to the point of necrosis.

Understanding the Trade-offs

Higher Power Is Not Automatically Better

The primary reference describes 30–35 W for interstitial vaporization of large, dense keloids. However, 1064 nm energy can cause nonspecific deep thermal injury, so power and pulse delivery must be individualized to lesion thickness, fiber position, treatment speed, and observed temperature.

Parameters used for other interstitial or transmucosal applications should not be transferred automatically to this keloid protocol. Published or device-specific settings may differ, and treatment must follow the applicable laser system instructions and clinical expertise.

Deep Damage May Be Delayed

Thermal injury is not always fully apparent at the moment of treatment. Tissue may later blister, ulcerate, slough, or become necrotic if heat was excessive or accumulated in overlapping zones.

For this reason, an apparently acceptable immediate surface appearance does not justify aggressive treatment or omission of follow-up.

Anatomical Structures Require Caution

Deep penetration creates a risk of injury to nearby nerves and other normal structures. High-risk areas containing major motor nerves, such as the parotid region near the facial nerve, require particular caution or may be unsuitable for this technique.

The fiber path must be planned around anatomy rather than determined solely by the visible keloid surface.

Recurrence Is Still Possible

Laser treatment can reduce scar volume and vascular support, but it does not guarantee permanent control. Keloids are biologically active scars with a significant tendency to recur, especially after ulceration, uncontrolled inflammation, or inadequate aftercare.

Adjunctive scar management and early treatment after future surgical procedures may be considered for patients with a strong keloid tendency. Low-fluence early postoperative laser strategies are described as one preventive approach, but they are distinct from high-power interstitial vaporization of an established lesion.

How to Apply This Safely

A safe protocol combines appropriate lesion selection, image- or pilot-beam-guided fiber placement, controlled moving delivery, temperature feedback, immediate cooling, and staged reassessment.

If your primary focus is treating a large, deep fibrotic keloid: Use specialist-guided interstitial delivery with a 400 or 600 µm bare fiber, controlled energy movement, and sessions spaced according to residual scar volume.
If your primary focus is preventing thermal necrosis: Prioritize continuous skin-temperature monitoring, avoid stationary treatment and pulse stacking, stop before epidermal injury or infarction, and apply immediate cooling.
If your primary focus is minimizing recurrence: Avoid ulceration and secondary-intention healing, monitor the lesion during follow-up, and consider a broader postoperative scar-prevention plan when future surgery is performed.

The safest treatment is the one that reduces deep scar tissue while preserving viable epidermis, surrounding dermis, and nearby anatomical structures.

Summary Table:

Step/Aspect	Key Details
Lesion Selection	Large, dense fibrotic keloids ≥1 cm diameter
Fiber Insertion	400-600 µm bare fiber via puncture guide, positioned with ultrasound or pilot beam
Energy Delivery	30-35 W, continuous or 0.1-0.3 sec chopped pulses, fiber slowly retracted
Temperature Monitoring	Continuous skin-surface temperature feedback essential
Cooling	Immediate post-laser cooling applied
Treatment Interval	Repeat every 8-10 weeks based on residual volume
Safety Endpoints	Avoid epidermal blanching, charring, infarction; preserve viable tissue

Elevate your clinical practice with BELIS's advanced laser systems, including Nd:YAG, designed for safe and effective treatment of deep fibrotic keloids. Our devices offer precise control and integrated safety features to minimize thermal necrosis. Partner with BELIS to access cutting-edge technology and expert support, ensuring optimal patient outcomes and practice growth. Contact us today to learn more about our professional-grade aesthetic equipment tailored for clinics and premium salons.